prikaz prve stranice dokumenta High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
  Download
PDF 522.46 KB
Scientific paper - Original scientific paper
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
Acta Diabetologica, 56 (2019), 9; 1045-1049. https://doi.org/10.1007/s00592-019-01346-1
Campbell, Matthew D.; Babic, Drazen; Bolcina, Uros; Smirčić-Duvnjak, Lea; Tankova, Tsvetalina; Mitrakou, Asimina; Kempler, Peter; Janez, Andrej

Cite this document

Campbell, M. D., Babic, D., Bolcina, U., Smirčić Duvnjak, L., Tankova, T., Mitrakou, A. ... Janez, A. (2019). High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study. Acta Diabetologica, 56. (9), 1045-1049. doi: 10.1007/s00592-019-01346-1

Campbell, Matthew D., et al. "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study." Acta Diabetologica, vol. 56, no. 9, 2019, pp. 1045-1049. https://doi.org/10.1007/s00592-019-01346-1

Campbell, Matthew D., Drazen Babic, Uros Bolcina, Lea Smirčić Duvnjak, Tsvetalina Tankova, Asimina Mitrakou, Peter Kempler and Andrej Janez. "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study." Acta Diabetologica 56, no. 9 (2019): 1045-1049. https://doi.org/10.1007/s00592-019-01346-1

Campbell, M. D., et al. (2019) 'High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study', Acta Diabetologica, 56(9), pp. 1045-1049. doi: 10.1007/s00592-019-01346-1

Campbell MD, Babic D, Bolcina U, Smirčić Duvnjak L, Tankova T, Mitrakou A, and sur.. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study. Acta Diabetologica [Internet]. 2019 September [cited 2024 May 06];56(9):1045-1049. doi: 10.1007/s00592-019-01346-1

M. D. Campbell, et al., "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study", Acta Diabetologica, vol. 56, no. 9, pp. 1045-1049, September 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:262710. [Accessed: 06 May 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
AuthorMatthew D. Campbell
AuthorDrazen Babic
AuthorUros Bolcina
AuthorLea Smirčić-Duvnjak
AuthorTsvetalina Tankova
AuthorAsimina Mitrakou
AuthorPeter Kempler
AuthorAndrej Janez
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Aims: Little is known regarding initiation of insulin therapy in type 2 diabetes (T2D) in Central and South-Eastern European countries. Therefore, we conducted a survey to characterise the prescribing practices of specialist diabetes healthcare professionals in this region and assessed factors that influence clinical decision-making regarding insulin initiation in T2D. ------ Methods: A cross-sectional survey sampled 211 specialist diabetes healthcare prescribers from five Central and South-Eastern European countries (Bulgaria, Croatia, Greece, Hungary, and Slovenia). A structured questionnaire was developed which surveyed current clinical practices and influencing factors, barriers to insulin initiation, and combination therapy prescribing preferences. ----- Result: Only 9.4% (20 of out of 211 respondents) of healthcare professionals would initiate insulin therapy in T2D patients at the recommended HbA1c threshold of 7-7.9% [53-63 mmol/mol]. Large regional differences were evident in insulin initiation thresholds (≥ 9.0% [≥ 75 mmol/mol]: Bulgaria 80.8% vs. Slovenia 13.3%). Psychological distress was recorded as the major barrier to insulin initiation. Health insurance regulations were ranked more important than personal clinical experience and clinical guidelines in clinical decision-making. Information from peers was more influential than manufacturer information, clinical experience, and continuous medical education, respectively, for insulin initiation. ----- Conclusions: Despite large regional variation, there is widespread delay of insulin initiation from specialist diabetes healthcare professionals in Central and South-Eastern Europe.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleActa Diabetologica
Numberingvol. 56, no. 9, pp. 1045-1049
p-ISSN0940-5429
DOIhttps://doi.org/10.1007/s00592-019-01346-1
URN:NBNurn:nbn:hr:105:262710
Publication2019-09
Document URLhttp://doi.org/10.1007/s00592-019-01346-1
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 10:34:45